TORII Pharmaceutical Co. Ltd.

09/16/2022 | Press release | Distributed by Public on 09/16/2022 00:04

Positive Top-line Results of Phase 3 Clinical Study (Comparative Study) of JTE-061 (tapinarof) Cream, Aryl Hydrocarbon Receptor (AhR) Agonist, in Patients with Plaque Psoriasis[...]